Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DTILPRECISION BIOSCIENCES INC

Nasdaq · CIK 0001357874
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end0521
XBRL facts331

Identity from submissions API

NamePRECISION BIOSCIENCES INC
CIK0001357874
TickersDTIL
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end0521
State of incorporationDE DE
Phone919-314-5512
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
302 EAST PETTIGREW STREET
SUITE A-100
DURHAM
NC
27701
NC
Mailing address
302 EAST PETTIGREW STREET
SUITE A-100
DURHAM
NC
27701
NC

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

611 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-004574 005-90975 261560518 34 10763
2026-11-12 4 FORM 4 0001628280-26-073391 5428
2026-11-10 144 xsl144X01/primary_doc.xml 0001959173-26-007893 001-38841 261538683 33 9746
2026-11-09 8-K 8-K 8.01,9.01 0001628280-26-071867 001-38841 261533756 34 147807 1 1
2026-11-06 144 xsl144X01/primary_doc.xml 0001959173-26-007836 001-38841 261532494 33 5228
2026-11-06 8-K 8-K 8.01,9.01 0001628280-26-071304 001-38841 261529279 34 18980977 1 1
2026-11-06 424B5 424B5 0001628280-26-071249 333-292478 261529008 33 515902
2026-11-05 144 xsl144X01/primary_doc.xml 0001959173-26-007799 001-38841 261527571 33 4689
2026-11-05 FWP FWP 0001628280-26-070552 333-292478 261524729 34 282234
2026-11-05 8-K 8-K 7.01,8.01,9.01 0001628280-26-070542 001-38841 261524665 34 10520728 1 1
2026-11-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-013679 005-90975 261517226 34 12401
2026-11-03 8-K 8-K 2.02,9.01 0001628280-26-069115 001-38841 261514341 34 249921 1 1
2026-11-03 10-Q 10-Q 0001628280-26-069092 001-38841 261514298 34 6624364 1 1
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003830 005-90975 261491659 34 10847
2026-09-30 4 FORM 4 0001628280-26-063980 4685
2026-09-29 4 FORM 4 0001628280-26-063767 4629
2026-09-29 4 FORM 4 0001628280-26-063766 4626
2026-08-24 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002033801-26-000004 005-90975 261310086 34 6782
2026-08-24 8-K 8-K 7.01,8.01,9.01 0001628280-26-058512 001-38841 261306316 34 177372 1 1
2026-08-07 S-8 S-8 0001628280-26-054602 333-298103 261251552 33 328492 1 1
2026-08-06 10-Q 10-Q 0001628280-26-053837 001-38841 261245965 34 6314117 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001628280-26-053836 001-38841 261245963 34 255127 1 1
2026-08-03 3 FORM 3 0001628280-26-051531 17917
2026-08-03 3 FORM 3 0001628280-26-051530 19921
2026-08-03 3 FORM 3 0001628280-26-051529 18356
2026-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004663 005-90975 261217732 34 12656
2026-07-27 8-K 8-K 5.02,7.01,9.01 0001628280-26-049665 001-38841 261202822 34 178166 1 1
2026-07-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-003172 005-90975 261186767 34 15055
2026-07-01 8-K 8-K 7.01,8.01,9.01 0001628280-26-046340 001-38841 261142575 34 151683 1 1
2026-06-16 8-K 8-K 1.01,2.03,9.01 0001628280-26-043526 001-38841 261094535 34 164436 1 1
2026-06-05 4 FORM 4 0001628280-26-041045 5763
2026-06-05 4 FORM 4 0001628280-26-041043 5819
2026-06-05 4 FORM 4 0001628280-26-041041 5762
2026-06-05 4 FORM 4 0001628280-26-041039 5822
2026-06-05 4 FORM 4 0001628280-26-041037 5823
2026-06-03 4 FORM 4 0001628280-26-040223 5804
2026-06-03 4 FORM 4 0001628280-26-040220 5753
2026-06-03 4 FORM 4 0001628280-26-040215 5749
2026-06-03 4 FORM 4 0001628280-26-040212 5763
2026-05-27 8-K 8-K 7.01,8.01,9.01 0001628280-26-038307 001-38841 261022167 34 810228 1 1
2026-05-26 8-K 8-K 5.02,5.03,5.07,9.01 0001628280-26-038220 001-38841 261021137 34 505911 1 1
2026-05-22 4 FORM 4 0001628280-26-037539 7374
2026-05-22 4 FORM 4 0001628280-26-037537 7373
2026-05-22 4 FORM 4 0001628280-26-037536 7314
2026-05-22 4 FORM 4 0001628280-26-037534 7373
2026-05-22 4 FORM 4 0001628280-26-037533 7313
2026-05-05 10-Q 10-Q 0001628280-26-030124 001-38841 26940451 34 5711543 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001628280-26-030123 001-38841 26940448 34 245616 1 1
2026-04-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-001989 005-90975 26862824 34 11291
2026-04-08 ARS ARS 0001140361-26-013759 001-38841 26846508 34 1448024
2026-04-08 DEFA14A DEFA14A 0001140361-26-013758 001-38841 26846506 34 2623108
2026-04-08 DEF 14A DEF 14A 0001140361-26-013757 001-38841 26846505 34 6616447 1 1
2026-03-27 PRE 14A PRE 14A 0001140361-26-011731 001-38841 26807277 34 6615859 1 1
2026-03-17 8-K 8-K 7.01,9.01 0001628280-26-018397 001-38841 26759209 34 6243229 1 1
2026-03-12 10-K 10-K 0001628280-26-017019 001-38841 26745658 34 10894560 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001628280-26-017018 001-38841 26745649 34 308216 1 1
2026-02-19 4 FORM 4 0001628280-26-009804 8995
2026-02-19 4 FORM 4 0001628280-26-009803 9024
2026-02-19 4 FORM 4 0001628280-26-009802 8992
2026-02-19 4 FORM 4 0001628280-26-009801 9736
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001183 001-38841 26649893 33 5372
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001166 001-38841 26648957 33 5144
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001164 001-38841 26648867 33 5180
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001157 001-38841 26648592 33 5130
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-26-002023 005-90975 26641476 34 13411
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001048 005-90975 26639374 34 10777
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001420506-26-000426 005-90975 26633983 34 10811
2026-02-11 8-K 8-K 7.01,8.01,9.01 0001628280-26-007114 001-38841 26618375 34 177644 1 1
2026-02-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-26-001399 005-90975 26614837 34 12178
2026-01-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001716774-26-000005 005-90975 26562463 34 8761
2026-01-22 4 FORM 4 0001628280-26-003149 16912
2026-01-22 4 FORM 4 0001628280-26-003148 16509
2026-01-22 4 FORM 4 0001628280-26-003147 16435
2026-01-22 4 FORM 4 0001628280-26-003146 17358
2026-01-22 144 xsl144X01/primary_doc.xml 0001959173-26-000404 001-38841 26551264 33 5215
2026-01-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000375 005-90975 26550786 34 16467
2026-01-21 144 xsl144X01/primary_doc.xml 0001959173-26-000389 001-38841 26548049 33 5171
2026-01-21 144 xsl144X01/primary_doc.xml 0001959173-26-000388 001-38841 26547969 33 4701
2026-01-21 144 xsl144X01/primary_doc.xml 0001959173-26-000387 001-38841 26547864 33 5163
2026-01-13 8-K 8-K 2.02,7.01,8.01,9.01 0001628280-26-001955 001-38841 26530219 34 186319 1 1
2026-01-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000100 333-292478 26517251 33 1788
2026-01-05 CORRESP filename1.htm 0001628280-26-000469 10201
2026-01-02 UPLOAD filename1.pdf 0000000000-26-000019 333-292478 40170
2025-12-30 S-3 S-3 0001628280-25-059077 333-292478 251611083 33 1230021 1 1
2025-12-30 S-8 S-8 0001628280-25-059075 333-292477 251611079 33 586947 1 1
2025-12-17 4 FORM 4 0001628280-25-057485 5012
2025-12-17 4 FORM 4 0001628280-25-057483 4551
2025-12-17 4 FORM 4 0001628280-25-057482 5013
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004969 005-90975 251484307 34 10608
2025-11-12 8-K 8-K 8.01,9.01 0001628280-25-051382 001-38841 251469637 34 917729 1 1
2025-11-12 424B5 424B5 0001628280-25-051369 333-272540 251469537 33 492350
2025-11-10 FWP FWP 0001628280-25-051175 333-272540 251467465 34 128587
2025-11-10 8-K 8-K 7.01,8.01,9.01 0001628280-25-051168 001-38841 251467433 34 209168 1 1
2025-11-04 4 FORM 4 0001628280-25-048858 9316
2025-11-04 4 FORM 4 0001628280-25-048856 9288
2025-11-04 4 FORM 4 0001628280-25-048855 9104
2025-11-03 144 xsl144X01/primary_doc.xml 0001959173-25-006677 001-38841 251443697 33 4536
2025-11-03 144 xsl144X01/primary_doc.xml 0001959173-25-006676 001-38841 251443693 33 4581
2025-11-03 144 xsl144X01/primary_doc.xml 0001959173-25-006674 001-38841 251443661 33 4541
2025-11-03 10-Q 10-Q 0001628280-25-047919 001-38841 251442070 34 7524948 1 1
2025-11-03 8-K 8-K 2.02,9.01 0001628280-25-047920 001-38841 251442067 34 237878 1 1
2025-09-30 4 FORM 4 0001628280-25-043156 4551
2025-09-24 4 FORM 4 0001628280-25-042524 4492
2025-09-02 8-K 8-K 5.02 0001357874-25-000005 001-38841 251282937 34 142843 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001011438-25-000451 005-90975 251219017 34 15684
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001420506-25-002095 005-90975 251215723 34 18165
2025-08-07 10-Q 10-Q 0001628280-25-038594 001-38841 251191614 34 6846093 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001628280-25-038592 001-38841 251191596 34 237544 1 1
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001591986-25-000007 005-90975 251190399 34 77538
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-074695 005-90975 251189352 34 46145
2025-08-06 8-K 8-K 7.01,8.01,9.01 0001628280-25-038094 001-38841 251187534 34 252987 1 1
2025-07-08 4 FORM 4 0001628280-25-034531 5377
2025-07-03 144 xsl144X01/primary_doc.xml 0001959173-25-004469 001-38841 251105336 33 4539
2025-06-27 4 FORM 4 0001628280-25-033200 5013
2025-06-27 4 FORM 4 0001628280-25-033199 5073
2025-06-04 4 4 0000950170-25-081728 9438
2025-06-04 4 4 0000950170-25-081727 9498
2025-06-04 4 4 0000950170-25-081726 9498
2025-06-04 4 4 0000950170-25-081725 9499
2025-06-04 4 4 0000950170-25-081724 9439
2025-06-04 4 4 0000950170-25-081723 5533
2025-06-04 4 4 0000950170-25-081722 5495
2025-06-04 4 4 0000950170-25-081721 5499
2025-06-04 4 4 0000950170-25-081720 5516
2025-06-03 8-K 8-K 5.07 0000950170-25-080564 001-38841 251017129 34 237303 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-007879 005-90975 25953320 34 30053
2025-05-15 8-K 8-K 2.02,7.01,9.01 0000950170-25-072016 001-38841 25948805 34 368052 1 1
2025-05-15 10-Q 10-Q 0000950170-25-071991 001-38841 25948728 34 9121513 1 1
2025-05-14 8-K 8-K 7.01,9.01 0000950170-25-071551 001-38841 25946624 34 222374 1 1
2025-04-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-001995 005-90975 25872656 34 9504
2025-04-15 ARS ARS 0001140361-25-013869 001-38841 25837637 34 13761852
2025-04-15 DEFA14A DEFA14A 0001140361-25-013868 001-38841 25837634 34 10668605
2025-04-15 DEF 14A DEF 14A 0001140361-25-013867 001-38841 25837632 34 6274382 1 1
2025-04-04 PRE 14A PRE 14A 0001140361-25-012168 001-38841 25812066 34 6286790 1 1
2025-03-28 4 4 0000950170-25-046331 4960
2025-03-28 4 4 0000950170-25-046332 4349
2025-03-27 4 4 0000950170-25-045720 4346
2025-03-26 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001011438-25-000193 005-90975 25774628 34 20263
2025-03-26 424B5 424B5 0000950170-25-045420 333-272540 25774173 33 51003
2025-03-26 10-K 10-K 0000950170-25-044775 001-38841 25770184 34 15122934 1 1
2025-03-26 8-K 8-K 2.02,9.01 0000950170-25-044764 001-38841 25770179 34 477920 1 1
2025-03-25 4 4 0000950170-25-044599 8977
2025-03-24 144 xsl144X01/primary_doc.xml 0001959173-25-002279 001-38841 25763853 33 5208
2025-03-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002033801-25-000002 005-90975 25749515 34 6246
2025-03-07 8-K 8-K 5.02 0000950170-25-035562 001-38841 25720534 34 163695 1 1
2025-03-05 4 4 0000950170-25-034010 9728
2025-03-05 4 4 0000950170-25-034006 7188
2025-03-05 4 4 0000950170-25-034016 8971
2025-03-05 144 xsl144X01/primary_doc.xml 0001959173-25-001711 001-38841 25710541 33 5148
2025-03-04 144 xsl144X01/primary_doc.xml 0001959173-25-001668 001-38841 25704588 33 5251
2025-03-04 144 xsl144X01/primary_doc.xml 0001959173-25-001667 001-38841 25704535 33 5178
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001591986-25-000002 005-90975 25625350 34 80654
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000047 005-90975 25625173 34 9561
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000981 005-90975 25623714 34 14557
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-012250 005-90975 25615843 34 45995
2025-01-29 8-K 8-K 5.02,9.01 0000950170-25-010209 001-38841 25566693 34 168236 1 1
2025-01-24 144 xsl144X01/primary_doc.xml 0001959173-25-000460 001-38841 25553760 33 4525
2025-01-22 4 4 0000950170-25-008014 13557
2025-01-22 4 4 0000950170-25-008012 11770
2025-01-22 4 4 0000950170-25-008013 13567
2025-01-22 4 4 0000950170-25-008011 14316
2025-01-22 144 xsl144X01/primary_doc.xml 0001959173-25-000418 001-38841 25545554 33 5176
2025-01-22 144 xsl144X01/primary_doc.xml 0001959173-25-000417 001-38841 25545552 33 4630
2025-01-21 144 xsl144X01/primary_doc.xml 0001959173-25-000388 001-38841 25542695 33 5228
2025-01-08 8-K 8-K 2.02,8.01 0000950170-25-003290 001-38841 25516620 34 170083 1 1
2025-01-02 4 4 0000950170-25-000071 4903
2024-12-31 4 4 0000950170-24-141309 4967
2024-12-31 4 4 0000950170-24-141308 4488
2024-12-30 4 4 0000950170-24-140921 4907
2024-11-21 4 4 0000950170-24-129735 4488
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258736 005-90975 241463740 34 59223
2024-11-14 SC 13G/A AMENDMENT NO. 1 0001214659-24-019111 005-90975 241461376 34 133593
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000119 005-90975 241459958 34 13096
2024-11-14 SC 13G PRECISION BIOSCIENCES INC 0000902664-24-006548 005-90975 241458529 34 49106
2024-11-05 4 4 0000950170-24-121729 7158
2024-11-05 4 4 0000950170-24-121727 8981
2024-11-05 4 4 0000950170-24-121726 8869
2024-11-04 144 xsl144X01/primary_doc.xml 0001959173-24-007376 001-38841 241423274 33 4545
2024-11-04 144 xsl144X01/primary_doc.xml 0001959173-24-007375 001-38841 241423256 33 4589
2024-11-04 10-Q 10-Q 0000950170-24-120279 001-38841 241420743 34 9948395 1 1
2024-11-04 8-K 8-K 2.02,9.01 0000950170-24-120278 001-38841 241420742 34 334709 1 1
2024-10-24 8-K 8-K 2.02,7.01,8.01,9.01 0000950170-24-116864 001-38841 241390837 34 218257 1 1
2024-09-12 8-K 8-K 5.02,7.01,9.01 0000950170-24-105706 001-38841 241293935 34 218111 1 1
2024-09-03 8-K 8-K 7.01,9.01 0000950170-24-102561 001-38841 241272047 34 195966 1 1
2024-08-23 4 4 0000950170-24-100021 5555
2024-08-23 4 4 0000950170-24-100020 5497
2024-08-23 4 4 0000950170-24-100019 5513
2024-08-23 4 4 0000950170-24-100018 5501
2024-08-01 10-Q 10-Q 0000950170-24-088951 001-38841 241164282 34 9621450 1 1
2024-08-01 8-K 8-K 2.02,9.01 0000950170-24-088950 001-38841 241164279 34 343350 1 1
2024-07-01 S-8 S-8 0000950170-24-079276 333-280618 241088215 33 646144
2024-06-11 4 4 0000950170-24-072052 9532
2024-06-11 4 4 0000950170-24-072050 7196
2024-06-11 4 4 0000950170-24-072049 10172
2024-06-10 144 xsl144X01/primary_doc.xml 0001959173-24-004313 001-38841 241032453 33 5173
2024-06-10 144 xsl144X01/primary_doc.xml 0001959173-24-004311 001-38841 241032435 33 5247
2024-06-10 8-K 8-K 5.02,5.07,9.01 0000950170-24-071082 001-38841 241031497 34 426144 1 1
2024-06-06 4 4 0000950170-24-069942 5604
2024-06-06 4 4 0000950170-24-069941 5664
2024-06-06 4 4 0000950170-24-069940 5660
2024-06-06 4 4 0000950170-24-069938 5603
2024-06-06 4 4 0000950170-24-069936 5663
2024-06-06 4 4 0000950170-24-069934 5672
2024-05-13 10-Q 10-Q 0000950170-24-058192 001-38841 24936861 34 8224960 1 1
2024-05-13 8-K 8-K 2.02,9.01 0000950170-24-058191 001-38841 24936855 34 347858 1 1
2024-05-08 4 4 0000950170-24-056141 4799
2024-05-08 4 4 0000950170-24-056140 4829
2024-05-08 4 4 0000950170-24-056139 5551
2024-05-08 4 4 0000950170-24-056138 4795
2024-05-08 8-K 8-K 8.01 0000950170-24-055089 001-38841 24924364 34 176344 1 1
2024-05-07 4 4 0000950170-24-054587 7173
2024-05-07 4 4 0000950170-24-054586 7174
2024-05-07 4 4 0000950170-24-054584 7182
2024-05-07 4 4 0000950170-24-054581 7111
2024-05-07 4 4 0000950170-24-054579 7170
2024-05-07 4 4 0000950170-24-054576 7113
2024-05-03 4 4 0000950170-24-053116 8843
2024-05-03 4 4 0000950170-24-053115 9773
2024-05-03 4 4 0000950170-24-053114 11817
2024-05-03 4 4 0000950170-24-053113 25911
2024-05-03 4 4 0000950170-24-053112 9787
2024-05-02 144 xsl144X01/primary_doc.xml 0001959173-24-003182 001-38841 24908644 33 5150
2024-05-02 144 xsl144X01/primary_doc.xml 0001959173-24-003173 001-38841 24907886 33 4545
2024-05-02 144 xsl144X01/primary_doc.xml 0001959173-24-003171 001-38841 24907867 33 4555
2024-05-02 144 xsl144X01/primary_doc.xml 0001959173-24-003170 001-38841 24907843 33 4588
2024-04-30 4 4 0000950170-24-050769 9731
2024-04-30 144 xsl144X01/primary_doc.xml 0001959173-24-003091 001-38841 24896908 33 4530
2024-04-25 ARS ARS 0001140361-24-022092 001-38841 24876969 34 2404839
2024-04-25 DEFA14A DEFA14A 0001140361-24-022090 001-38841 24876947 34 895677
2024-04-25 DEF 14A DEF 14A 0001140361-24-022084 001-38841 24876915 34 2422625
2024-04-22 4 4 0000950170-24-046599 5554
2024-04-22 4 4 0000950170-24-046598 5512
2024-04-22 4 4 0000950170-24-046597 5543
2024-04-22 4 4 0000950170-24-046596 5496
2024-04-16 8-K 8-K 1.02,2.02,7.01,9.01 0000950170-24-044831 001-38841 24848414 34 240830 1 1
2024-03-27 10-K 10-K 0000950170-24-036817 001-38841 24785770 34 16228600 1 1
2024-03-27 8-K 8-K 2.02,9.01 0000950170-24-036816 001-38841 24785768 34 463798 1 1
2024-03-18 SC 13G dtil_13gv3.htm 0001591986-24-000004 005-90975 24760213 34 94734
2024-03-14 SC 13G SC 13G 0001193125-24-067909 005-90975 24750277 34 64621
2024-03-11 SC 13G JHBIF >5% 0001274173-24-000064 005-90975 24737039 34 13539
2024-03-04 424B5 424B5 0001104659-24-030096 333-272540 24712188 33 639140
2024-03-01 8-K FORM 8-K 8.01,9.01 0001104659-24-029636 001-38841 24707014 34 687348 1 1
2024-03-01 FWP FWP 0001104659-24-029538 333-272540 24706706 34 12737
2024-02-29 424B5 424B5 0001104659-24-029458 333-272540 24705155 33 663525
2024-02-14 SC 13G/A greatpoint-dtil123123a1.htm 0001172661-24-001523 005-90975 24639377 34 110422
2024-02-13 8-K 8-K 5.03,9.01 0000950170-24-014194 001-38841 24622699 34 197024 1 1
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0001422848-24-000244 005-90975 24618118 34 18338
2024-02-05 SC 13G d125241sc13g.htm 0001214659-24-001943 005-90975 24596475 34 93711
2024-01-23 4 FORM 4 SUBMISSION 0001209191-24-002121 7632
2024-01-23 4 FORM 4 SUBMISSION 0001209191-24-002119 9622
2024-01-23 4 FORM 4 SUBMISSION 0001209191-24-002117 9614
2024-01-23 4 FORM 4 SUBMISSION 0001209191-24-002115 9622
2024-01-23 4 FORM 4 SUBMISSION 0001209191-24-002113 10804
2024-01-23 8-K 8-K 5.02,9.01 0000950170-24-006661 001-38841 24553625 34 806407 1 1
2024-01-23 144 xsl144X01/primary_doc.xml 0001959173-24-000429 001-38841 24552968 33 4493
2024-01-22 144 xsl144X01/primary_doc.xml 0001959173-24-000395 001-38841 24548668 33 5069
2024-01-22 144 xsl144X01/primary_doc.xml 0001959173-24-000394 001-38841 24548649 33 4372
2024-01-22 144 xsl144X01/primary_doc.xml 0001959173-24-000393 001-38841 24548648 33 5038
2024-01-19 8-K 8-K 5.07 0000950170-24-005581 001-38841 24543720 34 177722 1 1
2024-01-12 DEFA14A DEFA14A 0000950170-24-004111 001-38841 24530608 34 38002
2024-01-11 8-K 8-K 1.01,2.02,3.02,7.01,9.01 0000950170-24-003761 001-38841 24528038 34 229349 1 1
2023-12-22 8-K 8-K 5.03,9.01 0000950170-23-072457 001-38841 231507200 34 528845 1 1
2023-12-04 DEFA14A DEFA14A 0000950170-23-067782 001-38841 231463634 34 1034843
2023-12-04 DEF 14A DEF 14A 0000950170-23-067780 001-38841 231463633 34 1183328
2023-11-22 PRE 14A PRE 14A 0000950170-23-065887 001-38841 231433873 34 1185632
2023-11-07 10-Q 10-Q 0000950170-23-059764 001-38841 231381540 34 10415333 1 1
2023-11-07 8-K 8-K 2.02,9.01 0000950170-23-059763 001-38841 231381537 34 339857 1 1
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054552 9421
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054549 9387
2023-11-06 4 FORM 4 SUBMISSION 0001209191-23-054546 7551
2023-11-03 144 xsl144X01/primary_doc.xml 0001959173-23-004539 001-38841 231376139 33 4318
2023-11-03 144 xsl144X01/primary_doc.xml 0001959173-23-004538 001-38841 231376131 33 4354
2023-10-27 4/A FORM 4/A SUBMISSION 0001209191-23-053784 5487
2023-10-25 8-K 8-K 3.01 0000950170-23-055002 001-38841 231344009 34 169861 1 1
2023-10-20 8-K/A 8-K/A 1.01,2.03 0000950170-23-054420 001-38841 231337679 34 175157 1 1
2023-10-19 8-K 8-K 1.01 0000950170-23-054027 001-38841 231333333 34 163471 1 1
2023-09-12 8-K 8-K 7.01,8.01,9.01 0000950170-23-047585 001-38841 231248986 34 245357 1 1
2023-09-07 8-K 8-K 5.02 0000950170-23-046872 001-38841 231240940 34 171455 1 1
2023-09-05 4 FORM 4 SUBMISSION 0001209191-23-048150 4859
2023-09-05 4 FORM 4 SUBMISSION 0001209191-23-048145 5618
2023-09-05 4 FORM 4 SUBMISSION 0001209191-23-048144 4859
2023-08-22 4 FORM 4 SUBMISSION 0001209191-23-046874 5150
2023-08-21 8-K/A 8-K/A 9.01 0000950170-23-043555 001-38841 231187309 34 2922770 1 1
2023-08-16 8-K 8-K 1.01,2.01,7.01,9.01 0000950170-23-042895 001-38841 231176201 34 247085 1 1
2023-08-04 8-K 8-K 2.02,9.01 0000950170-23-038328 001-38841 231142192 34 337802 1 1
2023-08-04 10-Q 10-Q 0000950170-23-038319 001-38841 231142163 34 8825313 1 1
2023-07-06 8-K 8-K 1.01,8.01,9.01 0000950170-23-031899 001-38841 231072124 34 1384470 1 1
2023-06-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-06-15 16:00:00 9999999995-23-001772 333-272540 231019256 33 1747
2023-06-13 CORRESP filename1.htm 0000950170-23-027714 14309
2023-06-12 UPLOAD filename1.pdf 0000000000-23-006285 40322
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035835 7765
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035792 11542
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035790 8300
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035789 13374
2023-06-09 S-3 S-3 0000950170-23-027138 333-272540 231003952 33 1464947
2023-06-08 144 xsl144X01/primary_doc.xml 0001959173-23-001714 001-38841 231001770 33 4315
2023-05-31 8-K 8-K 7.01,8.01,9.01 0000950170-23-025091 001-38841 23978935 34 264604 1 1
2023-05-09 8-K 8-K 5.07 0000950170-23-019716 001-38841 23902362 34 222655 1 1
2023-05-09 10-Q 10-Q 0000950170-23-019132 001-38841 23899958 34 7525943 1 1
2023-05-09 8-K 8-K 2.02,9.01 0000950170-23-019130 001-38841 23899946 34 353466 1 1
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-027927 5816
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-027926 5817
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-027928 5825
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-027925 5816
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-027924 5757
2023-05-08 4 FORM 4 SUBMISSION 0001209191-23-027922 5756
2023-04-28 4 FORM 4 SUBMISSION 0001209191-23-026066 9254
2023-04-28 8-K 8-K 3.01 0000950170-23-015876 001-38841 23867074 34 179339 1 1
2023-04-27 144 xsl144X01/primary_doc.xml 0001959173-23-000709 001-38841 23856017 33 4920
2023-04-18 8-K 8-K 2.02,7.01,9.01 0000950170-23-013169 001-38841 23825534 34 217839 1 1
2023-04-13 4 FORM 4 SUBMISSION 0001209191-23-024206 7329
2023-03-23 ARS ARS 0001140361-23-013435 001-38841 23756719 34 1482541
2023-03-23 DEFA14A DEFA14A 0001140361-23-013433 001-38841 23756701 34 702584
2023-03-23 DEF 14A DEF 14A 0001140361-23-013430 001-38841 23756671 34 2356052
2023-03-23 4 FORM 4 SUBMISSION 0001209191-23-020716 9261
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020154 5149
2023-03-10 8-K 8-K 7.01 0000950170-23-007314 001-38841 23724247 34 169402 1 1
2023-03-09 8-K 8-K 2.02,9.01 0000950170-23-006840 001-38841 23718171 34 491468 1 1
2023-03-09 10-K 10-K 0000950170-23-006838 001-38841 23718169 34 14895773 1 1
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016866 10751
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016857 9230
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016842 9703
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016835 8977
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016824 7404
2023-03-06 144 xsl144X01/primary_doc.xml 0001959173-23-000151 001-38841 23709964 33 4313
2023-02-27 SC 13G greatpoint-dtil021723.htm 0001172661-23-001524 005-90975 23674290 34 112762
2023-02-24 8-K 8-K 5.02,7.01,9.01 0000950170-23-004240 001-38841 23662338 34 228086 1 1
2023-02-14 SC 13G/A greatpoint-dtil123122a1.htm 0001172661-23-001381 005-90975 23631084 34 112780
2023-02-13 SC 13G/A SEC SCHEDULE 13G 0001422849-23-000073 005-90975 23617618 34 18282
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016757 005-90975 23604041 34 13037
2023-01-27 SC 13G/A SC 13G/A 0000059478-23-000022 005-90975 23564015 34 56406
2023-01-24 4 FORM 4 SUBMISSION 0001209191-23-004611 5660
2023-01-24 4 FORM 4 SUBMISSION 0001209191-23-004610 5616
2023-01-24 4 FORM 4 SUBMISSION 0001209191-23-004609 5647
2023-01-24 4 FORM 4 SUBMISSION 0001209191-23-004608 5630
2023-01-24 4 FORM 4 SUBMISSION 0001209191-23-004607 5617
2023-01-24 4 FORM 4 SUBMISSION 0001209191-23-004606 5663
2023-01-09 8-K 8-K 2.02,7.01,8.01,9.01 0000950170-23-000453 001-38841 23516744 34 282598 1 1
2022-11-10 8-K 8-K 5.02,7.01,9.01 0000950170-22-024562 001-38841 221378328 34 212087 1 1
2022-11-08 8-K 8-K 2.02,7.01,9.01 0000950170-22-022894 001-38841 221367178 34 479418 1 1
2022-11-08 10-Q 10-Q 0000950170-22-022893 001-38841 221367177 34 8932682 1 1
2022-11-04 4 FORM 4 SUBMISSION 0001209191-22-055799 5700
2022-11-04 4 FORM 4 SUBMISSION 0001209191-22-055788 5689
2022-11-04 4 FORM 4 SUBMISSION 0001209191-22-055786 5667
2022-10-26 4 FORM 4 SUBMISSION 0001209191-22-054587 5805
2022-10-18 4 FORM 4 SUBMISSION 0001209191-22-053956 9067
2022-09-26 4 FORM 4 SUBMISSION 0001209191-22-051240 6643
2022-09-09 3 FORM 3 SUBMISSION 0001209191-22-049253 17263
2022-09-02 8-K 8-K 5.02,7.01,9.01 0000950170-22-018056 001-38841 221223211 34 249137 1 1
2022-08-31 SC 13G/A SC 13G/A 0001564590-22-030580 005-90975 221216246 34 75226
2022-08-26 S-8 S-8 0001564590-22-030152 333-267079 221199514 33 220828
2022-08-08 10-Q Q2 2022 10-Q 0001564590-22-028299 001-38841 221142544 34 8088440 1 1
2022-08-08 8-K 8-K 2.02,7.01,9.01 0001564590-22-028298 001-38841 221142535 34 427887 1 1
2022-07-18 8-K 8-K 2.02,8.01 0001564590-22-025887 001-38841 221088123 34 175296 1 1
2022-07-08 SC 13G us74019p1084_070822.txt 0000834237-22-010267 005-90975 221075023 34 12347
2022-07-01 SC 13G greatpoint-dtil062422.htm 0001172661-22-001552 005-90975 221060926 34 111875
2022-06-27 3 OWNERSHIP DOCUMENT 0001104659-22-074790 5812
2022-06-27 SC 13G SC 13G 0001104659-22-074786 005-90975 221045100 34 114261
2022-06-24 4 FORM 4 SUBMISSION 0001209191-22-039100 4597
2022-06-22 8-K 8-K 8.01,9.01 0001564590-22-023955 001-38841 221032981 34 595462 1 1
2022-06-22 424B4 424B4 0001564590-22-023954 333-238857 221032979 33 685578
2022-06-21 8-K 8-K 1.01,3.02,7.01,9.01 0001564590-22-023780 001-38841 221028852 34 1795347 1 1
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035417 13269
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035410 13263
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035405 11427
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035391 7400
2022-06-08 8-K 8-K 2.02,7.01,8.01,9.01 0001564590-22-022723 001-38841 221002580 34 269254 1 1
2022-05-31 4 FORM 4 SUBMISSION 0001209191-22-032729 5439
2022-05-31 3 FORM 3 SUBMISSION 0001209191-22-032727 6512
2022-05-31 8-K BROWN APPOINTMENT 8-K 5.02,7.01,9.01 0001564590-22-021763 001-38841 22980560 34 201590 1 1
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028453 5537
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028451 5546
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028449 5478
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028447 5537
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028445 5495
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028443 5538
2022-05-12 8-K 8-K - ANNUAL SHAREHOLDER MEETING VOTING RESULTS 5.07 0001564590-22-019668 001-38841 22915634 34 198078 1 1
2022-05-09 10-Q Q3 2022 10-Q 0001564590-22-018698 001-38841 22903250 34 6214303 1 1
2022-05-09 8-K 8-K 2.02,7.01,9.01 0001564590-22-018699 001-38841 22903247 34 332531 1 1
2022-04-28 4 FORM 4 SUBMISSION 0001209191-22-026041 12828
2022-04-13 4 FORM 4 SUBMISSION 0001209191-22-024302 8058
2022-04-11 8-K 8-K 2.02,7.01 0001564590-22-014047 001-38841 22818472 34 179370 1 1
2022-03-29 DEFA14A DEFA14A 0001140361-22-011650 001-38841 22781342 34 488878
2022-03-29 DEF 14A DEF 14A 0001140361-22-011648 001-38841 22781295 34 2413551
2022-03-23 4 FORM 4 SUBMISSION 0001209191-22-020793 8222
2022-03-21 4 FORM 4 SUBMISSION 0001209191-22-020337 5117
2022-03-15 10-K 10-K 0001564590-22-010222 001-38841 22739133 34 17355096 1 1
2022-03-15 8-K 8-K 2.02,7.01,9.01 0001564590-22-010220 001-38841 22739121 34 344421 1 1
2022-03-07 4 FORM 4 SUBMISSION 0001209191-22-016664 8241
2022-03-07 4 FORM 4 SUBMISSION 0001209191-22-016650 8264
2022-03-07 4 FORM 4 SUBMISSION 0001209191-22-016641 12877
2022-03-07 4 FORM 4 SUBMISSION 0001209191-22-016629 15891
2022-03-07 4 FORM 4 SUBMISSION 0001209191-22-016614 11336
2022-02-11 SC 13G/A SEC SCHEDULE 13G 0001422849-22-000077 005-90975 22619916 34 18223
2022-02-10 SC 13G SCHEDULE 13G 0001104659-22-018363 005-90975 22610622 34 13009
2022-02-10 SC 13G/A SC 13G/A 0001564590-22-004507 005-90975 22609527 34 63757
2022-02-03 SC 13G/A us74019p1084_020222.txt 0000834237-22-005478 005-90975 22585721 34 13377
2022-01-10 8-K 8-K 2.02,7.01,9.01 0001564590-22-000780 001-38841 22519828 34 195946 1 1
2021-12-21 8-K 8-K 7.01,8.01,9.01 0001564590-21-060767 001-38841 211506819 34 203320 1 1
2021-12-13 8-K 8-K 8.01 0001564590-21-060064 001-38841 211486966 34 201482 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (331 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 27.94M 2026-10-29 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
dei EntityPublicFloat Entity Public Float USD 47.10M 2025-06-30 2025 FY 10-K 2026-03-12 0001628280-26-017019
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.04M 2025-01-01 2025-12-31 DEF 14A 2026-04-08 0001140361-26-013757
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.02M 2025-01-01 2025-12-31 DEF 14A 2026-04-08 0001140361-26-013757
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.26M 2025-01-01 2025-12-31 DEF 14A 2026-04-08 0001140361-26-013757
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.19M 2025-01-01 2025-12-31 DEF 14A 2026-04-08 0001140361-26-013757
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 11.65 2025-01-01 2025-12-31 DEF 14A 2026-04-08 0001140361-26-013757
ffd NetFeeAmt NetFeeAmt USD 4,730.06 2026-08-06 S-8 2026-08-07 0001628280-26-054602
ffd TtlFeeAmt TtlFeeAmt USD 4,730.06 2026-08-06 S-8 2026-08-07 0001628280-26-054602
ffd TtlOfferingAmt TtlOfferingAmt USD 34.25M 2026-08-06 S-8 2026-08-07 0001628280-26-054602
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-06 S-8 2026-08-07 0001628280-26-054602
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 813,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 1.85M 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032150
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 1.44M 2020-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052737
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 240,000 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032150
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 28.69M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 639.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.96M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 121,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.35M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 36,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap Assets Assets USD 120.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AssetsCurrent Assets, Current USD 86.58M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 16.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap AssetsHeldForSaleLongLivedFairValueDisclosure Assets Held-for-sale, Long Lived, Fair Value Disclosure USD 169,000 2024-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 100,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 1.56M 2022-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036817
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 81.70M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 15.70M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 122.91M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032150
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 108.03M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -29.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 8.61M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 27.92M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 27.89M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized USD 2,900 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027213
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0000950170-24-120279
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 26.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 52.44M 2019-03-31 2019 Q1 10-Q 2019-04-29 0001564590-19-013706
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 997,000 2018-12-31 2020 Q1 10-Q 2020-05-15 0001564590-20-025635
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010222
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.1 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-088951
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.093 2024-06-30 2024 Q2 10-Q 2024-08-01 0000950170-24-088951
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 66,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027213
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 5.99M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006838
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 1.26M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 1.26M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredRentCredit Deferred Rent Credit USD 4,800 2020-01-01 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 390,000 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032150
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 4.09M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 16.49M 2019-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009541
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 65.89M 2019-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009541
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 5.10M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032150
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 26,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 22.53M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD 1.46M 2019-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009541
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 73.79M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 12.82M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 36.04M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 1.10M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 145.28M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 43,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 1.46M 2019-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009541
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 601,000 2020-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010222
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 1.30M 2023-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap DefinedContributionPlanAdministrativeExpenses Defined Contribution Plan, Administrative Expense USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 800,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2011-01-01 2011-01-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 774,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap DerivativeLiabilities Derivative Liability USD 23.97M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share USD/shares 0.07 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share USD/shares 0.07 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 12.35M 2022-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036817
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.26 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.46 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001564590-22-018698
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.26 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.213 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Percent pure 0.001 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.014 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.412 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.095 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 1.14M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.159 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.051 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure 1.184 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.48M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 15.80M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 7.00M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap EquityFairValueAdjustment Equity, Fair Value Adjustment USD 274,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-055930
us-gaap EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity Equity Method Investment, Difference Between Carrying Amount and Underlying Equity USD 0 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.5 2021-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010222
us-gaap EquityMethodInvestments Equity Method Investments USD 2.17M 2022-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036817
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD -3.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap EquitySecuritiesFVNINoncurrent EquitySecuritiesFVNINoncurrent USD 744,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap EscrowDeposit Escrow Deposit USD 3.80M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 8.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings USD 630,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036817
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases USD 11.37M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-059764
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 3.21M 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-071991
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -2,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010222
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD -30,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010222
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales USD -28,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010222
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -3.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 188,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 284,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 1.50M 2021-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010222
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 100,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 100,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 100,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 100,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 100,000 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 1.17M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap FiniteLivedLicenseAgreementsGross Finite-Lived License Agreements, Gross USD 1.49M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 855,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap GainsLossesOnSalesOfAssets Gain (Loss) on Disposition of Assets for Financial Service Operations USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 21.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 712,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006838
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 200,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 200,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -46.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -45.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -45.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -3.63 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -3.63 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 885,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 9.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -9.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD -97,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 182,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 2.94M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 4.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 497,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 15.99M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-12 0001564590-19-042519
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.44M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032150
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap IncreaseDecreaseInMarketableSecuritiesRestricted Increase (Decrease) in Marketable Securities, Restricted USD -958,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap IncreaseDecreaseInNotesReceivables Increase (Decrease) in Notes Receivables USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 141,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-04-29 0001564590-19-013706
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 391,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 852,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032150
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 2.46M 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-08 0001564590-22-028299
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 1.06M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap InterestExpense Interest Expense USD 354,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0000950170-25-071991
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 918,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap InterestIncomeOther Interest Income, Other USD 2.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 901,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 364,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-08 0001564590-22-028299
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 150,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LeaseCost Lease, Cost USD 1.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 6.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.27M 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036817
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.08M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.27M 2024-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.27M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.14M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 513,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 705,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap Liabilities Liabilities USD 68.60M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 120.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LiabilitiesCurrent Liabilities, Current USD 8.27M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 24.16M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 128,000 2023-12-31 2024 Q3 10-Q 2024-11-04 0000950170-24-120279
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap LoansPayable Loans Payable USD 22.42M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap LoansPayableCurrent Loans Payable, Current USD 22.41M 2023-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap LongTermDebt Long-term Debt USD 22.22M 2022-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036817
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 148,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 11.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -313,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -40.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -58.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 11.90M 2023-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingExpenses Operating Expenses USD 59.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -48.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.29M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.66M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.64M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.76M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 17.97M 2019-12-31 2020 Q3 10-Q 2020-11-10 0001564590-20-052737
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.71M 2019-12-31 2020 Q3 10-Q 2020-11-10 0001564590-20-052737
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 2.61M 2019-12-31 2020 Q3 10-Q 2020-11-10 0001564590-20-052737
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 3.29M 2019-12-31 2020 Q3 10-Q 2020-11-10 0001564590-20-052737
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 3.20M 2019-12-31 2020 Q3 10-Q 2020-11-10 0001564590-20-052737
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 3.10M 2019-12-31 2020 Q3 10-Q 2020-11-10 0001564590-20-052737
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 3.07M 2019-12-31 2020 Q3 10-Q 2020-11-10 0001564590-20-052737
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 2.71M 2019-12-31 2020 Q2 10-Q 2020-08-13 0001564590-20-039797
us-gaap OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate Operating Leases of Lessee, Contingent Rentals, Basis Spread on Variable Rate pure 0.03 2020-06-30 2020 Q2 10-Q 2020-08-13 0001564590-20-039797
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.092 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 445,000 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032150
us-gaap OtherAssetsCurrent Other Assets, Current USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 124,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 527,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 302,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OtherNoncashIncome Other Noncash Income USD 17.89M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006838
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -10.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationReceived1 Other Significant Noncash Transaction, Value of Consideration Received USD 17.89M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006838
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 13,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006838
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 190,000 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-04 0000950170-23-038319
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 1.40M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009541
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 4.72M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 39.55M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 8.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 135.19M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 4.99M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036817
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 109.74M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009541
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 19.80M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-27 0000950170-24-036817
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 662,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 15,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009541
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 31,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -58.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 30.12M 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 779,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 2.50M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-006838
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 38.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap RestrictedCash Restricted Cash USD 26.34M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 26.34M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -586.87M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 10.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap Revenues Revenues USD 1.07B 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009541
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 0 2025-11-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 18,118 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 4.94 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 2.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 3.03M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 6.93 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 720,490 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 8.4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 6.80M 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027213
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 155,282 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 176.53 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 22,880 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 255.83 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 146,113 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 151.4 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 168,993 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 165.54 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 155,282 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 168,993 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap SharePrice Share Price USD/shares 8.65 2019-03-31 2019 Q1 10-Q 2019-04-29 0001564590-19-013706
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 348,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 51.77M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 30 2024-02-13 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap StockIssued1 Stock Issued USD 49.49M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 49.49M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014005
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 104,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 150,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 31,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-26 0000950170-25-044775
us-gaap SubleaseIncome Sublease Income USD 467,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap TreasuryStockValue Treasury Stock, Value USD 952,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap UndistributedEarnings Undistributed Earnings, Basic USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-15 0001564590-22-010222
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 8.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001628280-26-017019
us-gaap VariableLeaseCost Variable Lease, Cost USD 310,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 23.97M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 25.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 61.03M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001564590-22-018698
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 25.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069092

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →